Evidence map›Paper›PMID 29854792›Full record

ReviewBioMed research international2018

Ginsenosides: A Potential Neuroprotective Agent.

Mengmeng Zheng, Yizhou Xin, Yujuan Li, Fangxue Xu, Xiaozhi Xi, Hong Guo, Xiaowei Cui, Hui Cao, Xi Zhang, Chunchao Han

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02796664 (Preventive Effects of Ginseng Against Atherosclerosis and Subsequent Ischemic Stroke), which is not on this map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02796664 nacompletednot on this map

Preventive Effects of Ginseng Against Atherosclerosis and Subsequent Ischemic Stroke: A Randomized Controlled Trial

TypeinterventionalSponsorDae Chul SuhRan2016 to 2018Enrolled58ConditionsIschemic Stroke, AtherosclerosisArmsGinseng, Placebo
3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 128 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Mengmeng ZhengSchool of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Yizhou XinThe Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China.
Yujuan LiSchool of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Fangxue XuSchool of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Xiaozhi XiSchool of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Hong GuoSchool of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Xiaowei CuiSchool of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Hui CaoSchool of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Xi ZhangSchool of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Chunchao HanSchool of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.ORCID 0000-0003-2843-7282
Shandong University of Traditional Chinese Medicine · CNAffiliated Hospital of Shandong University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ginseng is a traditional Chinese medicine with a wide range of pharmacological activities. Ginsenosides are the major constituents of ginseng. Ginsenosides have the unique biological activity and medicinal value, such as antitumor, anti-inflammatory, antioxidation, and inhibition of cell apoptosis. With the increase of stress in life, the incidence of nervous system diseases is also increasing. Neurological diseases pose a huge burden on people's life and health. In recent years, some studies have shown that ginsenosides have a certain role in the prevention and treatment of neurological diseases. However, the research is still in its infancy, and the relevant mechanisms are complex. In the paper, we review the effects and mechanisms of ginsenosides on epilepsy, depression, cerebral ischemia reperfusion injury, Alzheimer's disease, and Parkinson's disease. We hope to provide a theoretical basis for the treatment of nervous system diseases by ginsenosides.

Indexed as

AnimalsGinsenosidesHumansMedicine, Chinese TraditionalNervous System DiseasesNeuroprotective AgentsPanaxGinsenosidesNeuroprotective Agents

Identifiers

PMID29854792
PMCPMC5964429
OpenAlexW2801050676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.